These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 20307397)
1. An analysis of the HumaPen Luxura HD pen: what is the role of 0.5-unit insulin dosing? Magnotti MA; Rayfield EJ J Diabetes Sci Technol; 2010 Mar; 4(2):357-8. PubMed ID: 20307397 [TBL] [Abstract][Full Text] [Related]
2. Half-unit dose accuracy with HumaPen Luxura HD: an insulin pen for patients who need precise dosing. Clark PE; Okenfuss CR; Campbell M J Diabetes Sci Technol; 2010 Mar; 4(2):353-6. PubMed ID: 20307396 [TBL] [Abstract][Full Text] [Related]
3. No effect of insulin pen with memory function on glycemic control in a patient cohort with poorly controlled type 1 diabetes: a randomized open-label study. Danne T; Forst T; Deinhard J; Rose L; Moennig E; Haupt A J Diabetes Sci Technol; 2012 Nov; 6(6):1392-7. PubMed ID: 23294785 [TBL] [Abstract][Full Text] [Related]
4. Analysis of the NovoPen® Echo for the delivery of insulin: a comparison of usability, functionality, and preference among pediatric subjects, their parents, and health care professionals. Reynholds C; Antal Z J Diabetes Sci Technol; 2010 Nov; 4(6):1476-8. PubMed ID: 21129344 [TBL] [Abstract][Full Text] [Related]
5. Novopen Echo® for the delivery of insulin: a comparison of usability, functionality and preference among pediatric subjects, their parents, and health care professionals. Olsen BS; Lilleøre SK; Korsholm CN; Kracht T J Diabetes Sci Technol; 2010 Nov; 4(6):1468-75. PubMed ID: 21129343 [TBL] [Abstract][Full Text] [Related]
6. A randomized, cross-over comparison of preference between two reusable insulin pen devices in pen-naïve adults with diabetes. Wong M; Abdulnabi R; Carey MA; Fu H Curr Med Res Opin; 2013 May; 29(5):465-73. PubMed ID: 23438454 [TBL] [Abstract][Full Text] [Related]
7. Half-Unit Insulin Pens: Disease Management in Patients With Diabetes Who Are Sensitive to Insulin. Klonoff DC; Nayberg I; Stauder U; Oualali H; Domenger C J Diabetes Sci Technol; 2017 May; 11(3):623-630. PubMed ID: 27898389 [TBL] [Abstract][Full Text] [Related]
8. Patient perspectives on the use of half-unit insulin pens by people with type 1 diabetes: a cross-sectional observational study. Piras de Oliveira C; Mitchell BD; Fan L; Garey C; Liao B; Bispham J; Vint N; Perez-Nieves M; Hughes A; McAuliffe-Fogarty A Curr Med Res Opin; 2021 Jan; 37(1):45-51. PubMed ID: 33108218 [TBL] [Abstract][Full Text] [Related]
10. Toddlers' diabetes: the lost insulin drop and SemiPens vs. DeciPen. Abul-Ainine AA; Abul-Ainine SA Pediatr Diabetes; 2014 Jun; 15(4):319-23. PubMed ID: 25584371 [TBL] [Abstract][Full Text] [Related]
11. FlexPen: addressing issues of confidence and convenience in insulin delivery. Korytkowski M; Niskanen L; Asakura T Clin Ther; 2005; 27 Suppl B():S89-100. PubMed ID: 16519040 [TBL] [Abstract][Full Text] [Related]
12. Dose Accuracy, Injection Force, and Usability Assessment of a New Half-Unit, Prefilled Insulin Pen. Kappes CM; Kershner JR; Morwick TM; Corrigan SM J Diabetes Sci Technol; 2018 Mar; 12(2):364-372. PubMed ID: 29084452 [TBL] [Abstract][Full Text] [Related]
13. Dose accuracy of the ClikSTAR, NovoPen 4, and Luxura insulin pens: results of laboratory and field studies. Friedrichs A; Basso N; Adler S J Diabetes Sci Technol; 2011 Sep; 5(5):1179-84. PubMed ID: 22027314 [TBL] [Abstract][Full Text] [Related]
14. Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes. Reimer T; Hohberg C; Pfützner AH; Jørgensen C; Jensen KH; Pfützner A Clin Ther; 2008 Dec; 30(12):2252-62. PubMed ID: 19167585 [TBL] [Abstract][Full Text] [Related]
15. Accuracy and preference assessment of prefilled insulin pen versus vial and syringe with diabetes patients, caregivers, and healthcare professionals. Pfützner A; Bailey T; Campos C; Kahn D; Ambers E; Niemeyer M; Guerrero G; Klonoff D; Nayberg I Curr Med Res Opin; 2013 May; 29(5):475-81. PubMed ID: 23402225 [TBL] [Abstract][Full Text] [Related]
16. Acceptability and safety of a new 3.0 ml re-usable insulin pen (HumaPen) in clinical use. Martin JM; Llewelyn JA; Ristic S; Bates PC Diabetes Nutr Metab; 1999 Oct; 12(5):306-9. PubMed ID: 10741343 [TBL] [Abstract][Full Text] [Related]
17. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients. Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035 [TBL] [Abstract][Full Text] [Related]
18. Acceptability of a reusable insulin pen, HumaPen Ergo, by patients with type 1 and type 2 diabetes. Ristic S; Bates PC; Martin JM; Llewelyn JA Curr Med Res Opin; 2002; 18(2):68-71. PubMed ID: 12017212 [TBL] [Abstract][Full Text] [Related]
20. Past 10-year status of insulin therapy for preschool-age Japanese children with type 1 diabetes. Yokota I; Amemiya S; Kida K; Sasaki N; Matsuura N; Diabetes Res Clin Pract; 2005 Mar; 67(3):227-33. PubMed ID: 15713355 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]